
CAS 58906-62-0
:Dabigatran Impurity 22
Description:
Dabigatran Impurity 22, identified by the CAS number 58906-62-0, is a chemical compound that is recognized as an impurity associated with the anticoagulant drug dabigatran etexilate. This substance is typically characterized by its molecular structure, which includes specific functional groups that may influence its chemical behavior and stability. As an impurity, it is important to monitor its presence during the synthesis and quality control of dabigatran to ensure the safety and efficacy of the final pharmaceutical product. The compound may exhibit properties such as solubility in organic solvents and varying degrees of reactivity, which are common in pharmaceutical impurities. Its identification and quantification are crucial in pharmaceutical analysis, often employing techniques like high-performance liquid chromatography (HPLC) or mass spectrometry. Understanding the characteristics of such impurities is essential for regulatory compliance and maintaining the integrity of drug formulations.
Formula:C7H13ClO2
Synonyms:- hexan-3-yl chloroformate
- 3-Hexanyl carbonochloridate
- hexan-3-yl carbonochloridate
- Dabigatran Etexilate iMpurity 35
- 3-Hexyl Chloroformate (>
- Carbonochloridic acid, 1-ethylbutyl ester
- 3-Hexyl Chloroformate (>80%)
- Dabigatran Impurity 34
- CAS_58906-62-0
- Dabigatran Impurity 69
- hexan-3-yl carbonochloridate? (Dabigatran Impurity)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Hexan-3-yl carbonochloridate
CAS:<p>Hexan-3-yl carbonochloridate</p>Purity:95%Molecular weight:164.63g/mol3-Hexyl Chloroformate (>80%)
CAS:<p>Stability Air Sensitive, Moisture Sensitive<br>Applications 3-Hexyl Chloroformate is a potential impurity in the synthesis of Dabigatran Etexilate Mesylate (D100150); a nonpeptide and direct thrombin inhibitor. Antithrombotic.<br>References Zheng, Y., et al.: Org. Process Res. Dev., 18, 744 (2014); Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002); Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002); Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)<br></p>Formula:C7H13ClO2Purity:>80%Color and Shape:NeatMolecular weight:164.63




